We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Réunion d’actionnaires le 23 novembre à 18h30 Regulatory News: Transgene (Paris:TNG) (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies...
Regulatory News: CE COMMUNIQUÉ NE PEUT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, EN AUSTRALIE, AU CANADA OU AU JAPON Transgene...
Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG) (“Transgene” or the “Company”), a biotech company that designs and develops viral-based immunotherapies, today announced the...
Les nouveaux résultats issus de l’essai de Phase 2b TIME incluent la corrélation entre l’immunogénicité induite par le vaccin thérapeutique et l’amélioration de la survie globale, et...
TG6002 has a Double Mechanism of Action (Oncolysis and Local Delivery of Chemotherapy) for Enhanced Anti-Tumor Selectivity and Activity First Readouts Expected in H2 2018 Regulatory...
Data presented at AASLD Liver Meeting 2017 Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, announces that the analyses...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions